Lactibiane Voyage
Natural health product licensed in Canada
- Licence holder
- PiLeJe
- NPN or DIN-HM
- 80014958
- Status
- Active licence
- Licence date
- 26 November 2009
- Revision date
- 23 April 2024
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus plantarum Source : Lp-115 | 6.6 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : LC-11 | 6.6 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Amidon de maïs, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 6 years | 1 Gélule | 1 day |
| Adultes | Not specified | 1 Gélule | 1 day |
| Adolescentes | Not specified | 1 Gélule | 1 day |
Uses authorised in Canada
Fournit des probiotiques qui sont bénéfiques pour la santé de la flore intestinale des gens en déplacement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Cesser l'utilisation et consulter un practicien de soins de santé si les symptômes de troubles digestifs se manifestent, s'aggravent ou persistent au-delà de 3 jours.
- Contre-indications
Nepas utiliser si vous souffrez de nausées, de la fièvre, de vomissements, de diarrhées sanglantes our de douleurs abdominales intenses. Ne pas utiliser si vous souffrez d'un déficit, immunitaire (e.g. sida, lymphome, patients subissant un traitement prolongé aux corticostéorides).
Source
Official Health Canada record, licence 80014958
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging